LOGIN  |  REGISTER
Terns Pharmaceuticals

Recent Insider Transactions - UroGen Pharma (NASDAQ: URGN)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
08/11/2025
Sell
$17.69
10,000
$177K
148,229
NASDAQ URGN UroGen Pharma
Smith Jason Drew / officer: General Counsel
07/28/2025
Sell
$19.14
7,522
$144K
41,492
NASDAQ URGN UroGen Pharma
Schoenberg Mark / officer: Chief Medical Officer
07/28/2025
Sell
$19.14
5,149
$99K
158,229